| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0008 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |